Literature DB >> 16097436

The effect of hepatic stimulator substance (HSS) on liver regeneration arrest induced by 5-HT2 receptor blockade.

Konstantinos N Tzirogiannis1, Georgios I Panoutsopoulos, George K Papadimas, Maria D Demonakou, Rosa I Hereti, Georgia A Manta, Kalliopi T Kourentzi, Vasiliki G Kondili, Katerina N Alexandropoulou, Michael G Mykoniatis.   

Abstract

BACKGROUND: The restorative effect of hepatic stimulator substance (HSS) against hepatic regeneration arrest induced by 5-HT2 receptor blockade was investigated.
MATERIALS AND METHODS: Male Wistar rats were subjected to 60-70% partial hepatectomy and to 5-HT2 receptor blockade at 16 h after partial hepatectomy by ketanserin administration (6 mg/kg bodyweight intraperitoneally; group I). HSS at the dose of 100 mg protein/kg bodyweight was administered at 10 or 17 h after partial hepatectomy in ketanserin-treated rats (groups II and III). The mitotic index in hematoxylin-eosin-stained liver sections, immunochemical detection of PCNA and Ki 67 nuclear antigens and the rate of [3H]-thymidine incorporation into hepatic DNA were used as indices of liver regeneration.
RESULTS: Liver regeneration, as evaluated by [3H]-thymidine incorporation into hepatic DNA, mitotic index, PCNA and Ki67 nuclear antigens, peaked at 40 h in groups I, II and III of rats and no significant differences were observed between the studied groups.
CONCLUSION: HSS administration is not capable of reversing the liver regeneration arrest induced by 5-HT2 receptor blockade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097436

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

1.  Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma.

Authors:  Yuan-Yuan Guo; Yuan Wu; Xiao-Wei Jia; Wei An
Journal:  Lab Invest       Date:  2017-08-21       Impact factor: 5.662

2.  Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C.

Authors:  Jennifer M Loftis; Benjamin J Morasco; Daniel Menasco; Dietmar Fuchs; Max Strater; Peter Hauser
Journal:  Open Infect Dis J       Date:  2010-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.